Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,990 shares at $2.55 ($5K) on 2022-09-23, disclosed to the SEC on 2022-09-30.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.35 | 65 | $153 | 3.1% |
| 2 | $2.31 | 65 | $150 | 3.1% |
| 3 | $2.23 | 65 | $145 | 3.0% |
| 4 | $2.35 | 65 | $153 | 3.1% |
| 5 | $2.51 | 65 | $163 | 3.4% |
| 6 | $2.59 | 65 |
| $168 |
| 3.5% |
| 7 | $2.59 | 65 | $168 | 3.5% |
| 8 | $2.62 | 65 | $170 | 3.5% |
| 9 | $2.55 | 65 | $166 | 3.4% |
| 10 | $2.44 | 70 | $171 | 3.5% |
| 11 | $2.38 | 70 | $167 | 3.4% |
| 12 | $2.36 | 70 | $165 | 3.4% |
| 13 | $2.39 | 70 | $167 | 3.4% |
| 14 | $2.42 | 70 | $169 | 3.5% |
| 15 | $2.15 | 70 | $151 | 3.1% |
| 16 | $2.24 | 70 | $157 | 3.2% |
| 17 | $2.22 | 40 | $89 | 1.8% |
| 18 | $2.21 | 70 | $155 | 3.2% |
| 19 | $2.46 | 70 | $172 | 3.5% |
| 20 | $2.45 | 70 | $172 | 3.5% |
| 21 | $2.51 | 70 | $176 | 3.6% |
| 22 | $2.47 | 70 | $173 | 3.6% |
| 23 | $2.49 | 70 | $174 | 3.6% |
| 24 | $2.56 | 65 | $166 | 3.4% |
| 25 | $2.54 | 65 | $165 | 3.4% |
| 26 | $2.59 | 65 | $168 | 3.5% |
| 27 | $2.51 | 65 | $163 | 3.4% |
| 28 | $2.55 | 65 | $166 | 3.4% |
| 29 | $2.49 | 65 | $162 | 3.3% |
| 30 | $2.57 | 65 | $167 | 3.4% |
| Total | $2.44 avg | 1,990 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-08-19 | $5K | — | Filing → |